# OR51I1

## Overview
The OR51I1 gene encodes the protein olfactory receptor family 51 subfamily I member 1, which is part of the extensive family of olfactory receptors. These receptors are a subset of G protein-coupled receptors (GPCRs), characterized by their seven-transmembrane domain structure, which is crucial for their role in detecting odorant molecules and initiating signal transduction pathways (Jimenez2021The). The OR51I1 protein is primarily involved in the olfactory system, where it contributes to the sense of smell by binding specific odorants and activating intracellular signaling cascades. Beyond its sensory function, OR51I1 has been implicated in various biological processes, including potential roles in cancer progression, particularly melanoma, through its involvement in key signaling pathways such as NF-KB and WNT (Biradar2020Identification). Despite its established role in olfaction, the broader implications of OR51I1 in human health and disease are still under investigation, highlighting the need for further research to fully understand its functions and potential as a therapeutic target.

## Structure
The OR51I1 protein is a member of the olfactory receptor family, which are G protein-coupled receptors (GPCRs) characterized by a seven-transmembrane domain structure. This structure is typical of GPCRs and involves a sequence of seven alpha-helical transmembrane regions that span the cell membrane (Jimenez2021The). The primary structure of OR51I1 consists of a specific sequence of amino acids that form these helices. The secondary structure is defined by these alpha helices, which are crucial for the receptor's function in signal transduction (Jimenez2021The).

The tertiary structure of OR51I1 involves the folding of these helices into a three-dimensional conformation, which is essential for its interaction with odorant molecules and subsequent activation of intracellular signaling pathways. The quaternary structure is generally not applicable to olfactory receptors, as they typically function as monomers (Jimenez2021The).

Post-translational modifications such as glycosylation and phosphorylation are common in GPCRs, including olfactory receptors like OR51I1. These modifications can influence receptor stability, localization, and function (Jimenez2021The). The OR51I1 gene may also exhibit natural variations that can affect its structure and function, as documented in the human Olfactory Receptor Mutation Database (hORMdb) (Jimenez2021The).

## Clinical Significance
The gene OR51I1 has been implicated in the progression of melanoma skin cancer. Studies using whole exome sequencing have identified OR51I1 as one of the genes potentially involved in the transformation of normal skin epithelial cells into melanoma cells. This suggests that mutations or altered expression of OR51I1 may contribute to melanoma progression, possibly through its involvement in the NF-KB and WNT signaling pathways, which are known to play roles in cancer development (Biradar2020Identification).

In addition to its role in melanoma, OR51I1 has been analyzed for its expression patterns across various cancer types. It was noted to have a low difference in expression in colon, breast, lung, and brain cancers compared to control groups, indicating that its expression level might not significantly vary across these cancer types (Sehovic2019Detection). However, the specific clinical implications of these expression patterns in relation to OR51I1 are not detailed in the available studies.

Overall, while OR51I1 is associated with melanoma, its broader clinical significance across other cancer types remains to be fully elucidated. Further research is needed to confirm its potential as a biomarker or therapeutic target in cancer.


## References


[1. (Biradar2020Identification) Shivaleela Biradar, K. M. Kiran Kumar, M. Naveen Kumar, and R. L. Babu. Identification of Clinical Variants Present in Skin Melanoma Using Exome Sequencing Data, pages 85–96. Springer International Publishing, 2020. URL: http://dx.doi.org/10.1007/978-3-030-46943-6_10, doi:10.1007/978-3-030-46943-6_10. This article has 0 citations.](https://doi.org/10.1007/978-3-030-46943-6_10)

[2. (Sehovic2019Detection) Emir Sehovic. Detection and analysis of stable and flexible genes towards a genome signature framework in cancer. Bioinformation, 15(10):772–779, October 2019. URL: http://dx.doi.org/10.6026/97320630015772, doi:10.6026/97320630015772. This article has 2 citations.](https://doi.org/10.6026/97320630015772)

[3. (Jimenez2021The) Ramón Cierco Jimenez, Nil Casajuana-Martin, Adrián García-Recio, Lidia Alcántara, Leonardo Pardo, Mercedes Campillo, and Angel Gonzalez. The mutational landscape of human olfactory g protein-coupled receptors. BMC Biology, February 2021. URL: http://dx.doi.org/10.1186/s12915-021-00962-0, doi:10.1186/s12915-021-00962-0. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12915-021-00962-0)